NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Supplement·Evidence index

Glucosamine and Warfarin: what the published research says

PubMed indexes 5 records that name Glucosamine and Warfarin together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Glucosamine and Warfarin. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

5 studies naming Glucosamine and Warfarin.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.

Pharmacotherapy · 2008 · PMID 18363538

Case ReportsReviewHuman subjects

“Patients should be advised that the use of the two products may cause an increase in INR, and they should inform their health care provider if they consume glucosamine. More information is necessary to define this interaction.”

Knudsen et al. · From the abstract

Names both Glucosamine and Warfarin in its title.

Glucosamine and chondroitin sulfate do not enhance anticoagulation activity of warfarin in mice in vivo

Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2014 · PMID 25212820

Animal study

“However, the two ingredients did not induce or inhibit hepatic CYPs, including (S)-warfarin hydroxylase. These findings suggest that glucosamine and chondroitin sulfate do not affect the anticoagulation activity of warfarin through hepatic CYP mediated-mechanisms.”

Yokotani et al. · From the abstract

Names both Glucosamine and Warfarin in its title.

Interaction of warfarin with glucosamine--chondroitin.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2004 · PMID 15237575

CommentLetterHuman subjects

Names both Glucosamine and Warfarin in its title.

Clinically significant CYP2C inhibition by noscapine but not by glucosamine.

Clinical pharmacology and therapeutics · 2010 · PMID 20668444

Comparative StudyControlled Clinical Trial

“Whereas glucosamine had no significant effect on CYP activity, noscapine caused marked inhibition of CYP2C9 (4.9-fold increase in urinary losartan/E3174 ratio) and CYP2C19 (3.6-fold increase in the plasma omeprazole/5-hydroxyomeprazole ratio). Noscapine-dependent inhibition of CYP2C9 may explain the interaction with warfarin.”

Rosenborg et al. · From the abstract

Names Glucosamine and Warfarin together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Glucosamine, Warfarin, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.